Investors
At BASF, we create chemistry for a sustainable future.
Latest Investor Releases
BASF drives forward structural adjustments at the Ludwigshafen site and closes production plants for adipic acid, CDon and CPon
BASF will end the production of adipic acid, cyclododecanone (CDon) and cyclopentanone (CPon) at the Ludwigshafen site. The production plant for CDon and CPon will be shut down in the first half of 2025 and the remaining adipic acid production in Ludwigshafen will be closed in the course of 2025. The company has taken this decision as part of the ongoing strategic review of its production setup at the Ludwigshafen site to ensure competitiveness under changing market conditions.
EBITDA before special items at level of prior-year quarter; outlook 2024 unchanged
“Overall, the development of EBITDA before special items in the second quarter of 2024 was in line with our expectations and the analyst consensus. We saw a continuation of the dynamics of the first quarter, marked by positive volume momentum across most of our businesses. There was still pressure on prices,” said Dr. Markus Kamieth, Chairman of the Board of Executive Directors of BASF SE, when presenting the figures for the second quarter of 2024 together with Chief Financial Officer Dr. Dirk Elvermann.